SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-390367
Filing Date
2014-10-31
Accepted
2014-10-30 21:24:38
Documents
7
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d811434d20f.htm 20-F 1686698
2 EX-8.1 d811434dex81.htm EX-8.1 11167
3 EX-12.1 d811434dex121.htm EX-12.1 9409
4 EX-12.2 d811434dex122.htm EX-12.2 9426
5 EX-13.1 d811434dex131.htm EX-13.1 4805
6 GRAPHIC g811434tx105.jpg GRAPHIC 10171
7 GRAPHIC g811434tx106.jpg GRAPHIC 7413
  Complete submission text file 0001193125-14-390367.txt   1747023
Mailing Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077
Business Address LEVEL 1 16 - 20 EDGEWORTH DAVID AVE HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 141184621
SIC: 2834 Pharmaceutical Preparations